Skip to main content

SelfDiagnostics from Estonia presents at MedTech Strategist Forum for investors

Pressmeddelande   •   Apr 10, 2019 10:38 CEST

Joining French SME Aenitis as a guest of EIT Health at the meeting in Dublin

The Estonian SME Self-diagnostics was one of two particularly promising European start-ups that EIT Health chose to invite to the Medtech Strategist Forum, which unites more than 450 leading key decision-makers and investors in Dublin, Ireland during 9-11 April 2019.


SelfDiagnostics is a medtech company, headquartered in Tallinn, Estonia, that produces medical self-tests. The company’s NINAAT (Non-Instrumented Nucleic Acid Amplification) molecular diagnostics innovations, using PCR (polymerase chain reaction) technology, can be used for varying diagnostics purposes, such as pharmaceuticals, food, veterinary, agriculture, military, or cosmetics. The first product is a multi-test for sexually transmitted diseases.

Selected by EIT Health Investor Network

SelfDiagnostics was joined by the French SME Aenitis at the investor’s forum. They were selected from a wide range of promising European start-ups by EIT Health Investor Network programme, and EIT Health funded their entrance ticket to the forum, valued at €2 000.

The Investor Network programme is an EIT Health Accelerator programme to enable international co-investments of venture capitalists, business angels networks and associations, family offices etc. to start-ups selected by EIT Health.

About the MedTech Strategist Forum

The MedTech Strategist Forum is recognised as the leading medical technology investment forum in Europe. It provides the opportunity to companies to meet with large European investors and pitch their business ideas to them, to attract possible new investments or discuss IPO opportunities. EIT Health is a supporter of the MedTech Strategist summit and is also represented at the top-tier event.

Find out more

EIT Health is one of the largest healthcare initiatives worldwide. Its goal is to sustainably advance the fundamentals of healthcare and thus promote suitable future conditions for healthy living, active ageing and improved wellbeing of people across Europe. EIT Health leverages the expertise of more than 135 member organisations from the pharma, diagnostics and med tech fields, payers, insurances, research institutions and universities. As one of the EIT’s Knowledge and Innovation Communities (KICs), the initiative benefits from some of the world’s best-in-class academic and research organisations and offers both higher education and business expertise. By investing in Europe’s best entrepreneurial talents and ideas, EIT Health fosters the development and commercialization of smart product and service solutions in the health sector, addressing the challenges posed by demographic change and ageing societies. 

Headquartered in Munich (Germany), EIT Health has six co-location centres in London (UK/Ireland), Stockholm (Scandinavia), Barcelona (Spain), Paris (France), Mannheim and Heidelberg (Germany/Switzerland) and Rotterdam (Belgium/Netherlands), as well as the “EIT Health InnoStars” cluster with partners linked to seven regions in six countries – Croatia, Hungary, Poland, Portugal, Italy and Wales.

EIT Health – Making healthy lives a reality for all